Daniel Scott Ory - 08 Sep 2026 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Reporting relationship: EVP, Chief Medical Officer
Issuer ticker: EDIT
Reported as of: 08 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Sep 2026, 16:58:20 UTC
Source filing: View source filing
Reporting owner signature: /s/ Daniel Ory, M.D.

Key filing fact

Daniel Scott Ory filed Form 4 for Editas Medicine, Inc. (EDIT) on 09 Sep 2026.

Key facts

This page summarizes Daniel Scott Ory's Form 4 filing for Editas Medicine, Inc. (EDIT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Sep 2026, 16:58.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002149618 Primary reporting owner

Ory Daniel Scott

Relationship: EVP, Chief Medical Officer
Address: C/O EDITAS MEDICINE, INC., 11 HURLEY STREET, CAMBRIDGE
Signature: /s/ Daniel Ory, M.D.
Signature date: 09 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EDIT transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +950,000
Change %
Price: $0.000000^*
Shares after: 950,000
Date: 08 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 950,000
Exercise price: $3.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted on September 8, 2026 and is scheduled to vest over four years, with 25% of the shares to vest on October 15, 2027 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through October 15, 2030.